NCT04696965
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Department of Thoracic Medicine, Chang Gung Memorial Hospital Taoyuan, Taiwan
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,727 public trials
630 recruiting studies
Hypersensitivity, Immediate trial results
NCT02219633
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- proinnovera GmbH, Center of Dermatology Excellence Münster, Germany
NCT00392067
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Clinique Dermatologique Maizerets Québec, Quebec, Canada
- Hudklinikken Nykøbing Falster, Denmark
- Helsinki University Central Hospital Helsinki, Finland
- Manchester Royal Infirmary Manchester, United Kingdom
NCT05099133
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- LEO Investigational Site Los Angeles, California, United States
NCT05147155
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- External Unit of Asthma of Respiratory Medicine Department of the University of Thessaly in Greece Larissa, Thessaly, Greece
NCT03826901
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- LEO Pharma investigational site Birmingham, Alabama, United States
- LEO Pharma investigational site Phoenix, Arizona, United States
- LEO Pharma investigational site Fountain Valley, California, United States
- LEO Pharma investigational site Irvine, California, United States
Completed
A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT02376049
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Innovaderm Research Inc. Montreal, Quebec, Canada
- Beit Harofim Netanya, Israel
Completed
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
NCT01005823
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- PRA International, University Medical Centre Groningen, Netherlands
NCT01850849
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Covance Clinical Research Unit, Hyde Street, Leeds, UK Leeds, United Kingdom
- Covance Royal Liverpool Clinical Research Unit Liverpool, United Kingdom
Completed
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
NCT03556592
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- LEO Pharma Investigational Site Little Rock, Arkansas, United States
- LEO Pharma Investigational Site Rogers, Arkansas, United States
- LEO Pharma Investigational Site San Diego, California, United States
- LEO Pharma Investigational Site Doral, Florida, United States